Gene search


Sequence information


Select Gene Cds Cds_length GC_content Pep Pep_length
Vra5g0034 ATGAGAGCTCCCACTCCCAGAGACACACCAACCCCATCAACATCAACATCATCAACAACAACAACAACGTCAACACCACCCTCTTCCATCTACATGATTCCCGACTTAATGGTCTTTGTCACTCTCCTGTTTCTTCTTCTCTCTGCCTTCCTTCTTCCTGTTCAAGCCGCCTCCTGTAACCAACTTGATAGAGACTCACTCTTGGCCTTCTCCAGGAACATATCCTCTCCTTCTCCTCTCAATTGGTCTTCTTCTGTTGATTGTTGTCTCTGGGAAGGCATTAAGTGTGATGACAATTTCAGAGTCATACATCTATTGCTACCATCCAGGGGTCTCGCCGGCTTCATCTTCCCATCACTCACAAATCTCACTGCTCTCTCCCTTCTTGATCTTTCCCAGAACCGCTTATCTGGTAATCTCCCAGACCAATTTTTCTCACTTCTTAATCACCTGCAGATTCTTGATTTAAGCTACAATCGTCTCTCTGGTGAACTGCCACCCTTTGTTCCTAATACCACTGGCAATACCATTCGGGAGCTTGATCTGTCCAGTAATTTATTCCACGGAAAACTACCACTCTCTCTCCTTCAGCACCTGGCAGATGCAATCGCAGCAGGGAGTTTGACATCTTTTAACGTTAGTAACAACAGCTTCACTGGTCAAATTCCCACTTCTCTCCTCTGCAATAACCACAGTAGCTCATCCTCTCTTAGATTCTTGGATTATTCCTCCAATGATTTCTCTGGCTTGATTCAGCCAGGACTAGGAGCATGTTCCAAGCTGGAGAGATTTCGAGCAGGCTCCAATTCCCTATCCGGGCCCCTTCCTGGTGATATTTTCGATGCTGTTTCTCTCAAAGAAATCTCCTTGCCCCTCAATAAACTCGGTGGAACCCTTGGTGAGAGCATTGTTAACCTTGTCAACCTCACAGTTTTGGAGCTCTACTCCAATAATTTCACCGGGCCCATTCCCTCTGATATTGGTAAGCTCTCCAAATTGGAACGTTTACTTCTTCATGCCAACAAAATAAATGGCACTCTTCCCCCATCTCTAATGGACTGTGTCAATCTTGTCATGTTGGATGTAAGGCTCAATTTATTGGAGGGAAGCCTCTCGGCATTGAATTTCTCCGGACTCCTCAGACTCTCAGCACTTGACCTCGGCAACAATAGTTTTACTGGTATTATACCACCAACCATGTATGCATGCAAATCCCTTAAAGCAGTGAGGCTTGCATCTAATCATTTTGAGGGGCAGATCTCACCTGATATACTTGGACTTCAGTCTCTGGCTTTCCTATCAATTTCTACCAACAACCTCAGTAATATCACAGGAGCTCTGAGGCTGCTTATGGGACTCAAGAACCTTAGCACTCTCATGCTCTCCCAGAATTTTTTCAATGAAATGATGCCAGATGATGTCAACATAACAAACCCAGATGGATTCCAAAAGATCCAAGTTCTAGGTTTGGGCGGTTGTAATTTCACAGGCCAAATACCACACTGGCTTTATAATCTGAAGAAGCTCGAGGTCTTGGATTTGTCCTATAATCAAATTAGTGGTTCAATTCCTCCTTGGTTGCACACGCTTCCCGAGCTTTTCTACGTAGACTTGTCTTTTAACCTCCTCACAGGAATGTTTCCAGCTGAGCTCACAACGCTTCCCGCACTAACATCACAACGGACCTATGACGAAGTAGAAAGGACTTACCTGGAGTTACCCGTGTTTGCTAATGCCAACAATGTCTCTCAGATGCAATACAATCAGATTTCCAACCTACCACCAGCAATATATCTGGGAAACAATAGCCTCAACGGCAGTATCCCGGTAGAGATTGGCAAACTCAGTGTTCTTCATCAGCTGGACCTTAGTAACAACAAATTCTCTGGCAATATCCCAGCGGAAATTTCTAACCTGATTAACTTAGAGAAACTATACCTCTCAGGAAACCAACTTTCCGGGGAAATTCCCGTTTCACTCAAAAGCTTGCATTTTTTGTCTGCTTTCAGTGTAGCATACAATAATCTTGAAGGACCGGTACCCACAGGTGGCCAATTTGATACTTTCTCCTTTTCTAGCTTCGAAGGAAACCCACAGTTGTGTGGGTCAGTTGTTCGGCGGTCTTGTCTTCCTCAACAGGGTACTACTGCTCGTAGTCACAGCTCAAGCAAAAAGCTGATAATTGGATTTGCCATTGCAGCCAGTTTTGGCCTTGTTTCCTTCGTTTCAGTGTTGATAGTGTGGGTAATATCCAAGAGGAGGATCAATCCAGGTGGAGAACCTGACAAGATTGAAGTAGAATCAATTTCTATCAGCTCTTACAGTGGGGTTCATCCCGAGGTTGACAAAGAGGCCAGCCAAGTGGTACTGTTCCCTAATAAAACAAGTGAAATCAAGGACCTTACCATAGTTGAAATATTAAAAGCTACTGAAAACTTCAGTCAGGCAAACATAATAGGATGTGGAGGTTTTGGTTTGGTGTATAAAGCAACATTACCAAATGGAACTGCTCTGGCCATTAAGAAACTTTCAGGAGAATTAGGTCTAATGGAAAGGGAATTTAAAGCAGAGGTAGAGGCTTTGTCGACAGCACAGCATGAGAATCTGGTTGCATTGCAAGGCTACTGTGTGCATGAGGGTGTTCGGCTTCTGATATACACTTACATGGAAAATGGAAGTCTGGATCACTGGCTACATGAGAAGGCAGATGGTCCATCTCAGATTGACTGGCCTACCCGACTGAAGATTGCACAAGGTGCAAGTTGTGGATTGGCTTACATGCACCAAATATGTGAACCACATATAGTGCATCGTGATATAAAGTCAAGCAATATACTTCTTGATGAAAAGTTTGAGGCACATGTTGCTGATTTTGGGCTGGCCAGACTCATTCTTCCTTATCACACTCACGTTACAACTGAACTTGTAGGCACATTAGGTTACATACCCCCAGAGTATGGACAAGCATGGGTGGCTACTCTGAGAGGAGACGTTTACAGCTTTGGGGTTGTCATGCTTGAGCTGCTAACGGGGAGAAGGCCTGTTGATGTAAGCAAGCCAAAAATGTCAAGGGAGTTAGTTGCCTGGGTTCAACAAATGAGGAGTGAAGGAAAACAAGATCAAGTCTTTGATCCATTTCTGAGAGGCAAGGGGTTTGAAGAACAGATGCTCAAGGTTCTTGATGTAGCCTGCATGTGTGTCAGCCATAATCCTTTCAAGAGACCCTGCATCCCAGAAGTTGTTGAATGGCTGAGGAATGTAGGATTATCCAACCACCATATGAATAAAGACTAG 3294 0.4429 MRAPTPRDTPTPSTSTSSTTTTTSTPPSSIYMIPDLMVFVTLLFLLLSAFLLPVQAASCNQLDRDSLLAFSRNISSPSPLNWSSSVDCCLWEGIKCDDNFRVIHLLLPSRGLAGFIFPSLTNLTALSLLDLSQNRLSGNLPDQFFSLLNHLQILDLSYNRLSGELPPFVPNTTGNTIRELDLSSNLFHGKLPLSLLQHLADAIAAGSLTSFNVSNNSFTGQIPTSLLCNNHSSSSSLRFLDYSSNDFSGLIQPGLGACSKLERFRAGSNSLSGPLPGDIFDAVSLKEISLPLNKLGGTLGESIVNLVNLTVLELYSNNFTGPIPSDIGKLSKLERLLLHANKINGTLPPSLMDCVNLVMLDVRLNLLEGSLSALNFSGLLRLSALDLGNNSFTGIIPPTMYACKSLKAVRLASNHFEGQISPDILGLQSLAFLSISTNNLSNITGALRLLMGLKNLSTLMLSQNFFNEMMPDDVNITNPDGFQKIQVLGLGGCNFTGQIPHWLYNLKKLEVLDLSYNQISGSIPPWLHTLPELFYVDLSFNLLTGMFPAELTTLPALTSQRTYDEVERTYLELPVFANANNVSQMQYNQISNLPPAIYLGNNSLNGSIPVEIGKLSVLHQLDLSNNKFSGNIPAEISNLINLEKLYLSGNQLSGEIPVSLKSLHFLSAFSVAYNNLEGPVPTGGQFDTFSFSSFEGNPQLCGSVVRRSCLPQQGTTARSHSSSKKLIIGFAIAASFGLVSFVSVLIVWVISKRRINPGGEPDKIEVESISISSYSGVHPEVDKEASQVVLFPNKTSEIKDLTIVEILKATENFSQANIIGCGGFGLVYKATLPNGTALAIKKLSGELGLMEREFKAEVEALSTAQHENLVALQGYCVHEGVRLLIYTYMENGSLDHWLHEKADGPSQIDWPTRLKIAQGASCGLAYMHQICEPHIVHRDIKSSNILLDEKFEAHVADFGLARLILPYHTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGRRPVDVSKPKMSRELVAWVQQMRSEGKQDQVFDPFLRGKGFEEQMLKVLDVACMCVSHNPFKRPCIPEVVEWLRNVGLSNHHMNKD* 1098
       

Annotation information


Select Seq ID Length Analysis Description Start End IPR GO
Vra5g0034 1097 Gene3D Ribonuclease Inhibitor 200 279 IPR032675 -
Vra5g0034 1097 SMART LRR_typ_2 148 172 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 330 354 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 427 449 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 506 530 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 306 329 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 123 147 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 639 663 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 615 638 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 379 403 IPR003591 -
Vra5g0034 1097 SMART LRR_typ_2 453 476 IPR003591 -
Vra5g0034 1097 Gene3D Ribonuclease Inhibitor 375 716 IPR032675 -
Vra5g0034 1097 SUPERFAMILY RNI-like 84 327 - -
Vra5g0034 1097 MobiDBLite consensus disorder prediction 7 26 - -
Vra5g0034 1097 PRINTS Leucine-rich repeat signature 126 139 - -
Vra5g0034 1097 PRINTS Leucine-rich repeat signature 148 161 - -
Vra5g0034 1097 PANTHER OS02G0155400 PROTEIN 37 1085 - -
Vra5g0034 1097 ProSiteProfiles Protein kinase domain profile. 813 1089 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vra5g0034 1097 Pfam Leucine rich repeat N-terminal domain 63 97 IPR013210 -
Vra5g0034 1097 Gene3D Transferase(Phosphotransferase) domain 1 889 1096 - -
Vra5g0034 1097 Pfam Leucine rich repeat 484 543 IPR001611 GO:0005515
Vra5g0034 1097 ProSitePatterns Serine/Threonine protein kinases active-site signature. 935 947 IPR008271 GO:0004672|GO:0006468
Vra5g0034 1097 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE FAMILY PROTEIN-RELATED 37 1085 - -
Vra5g0034 1097 ProSiteProfiles Leucine-rich repeat profile. 508 531 IPR001611 GO:0005515
Vra5g0034 1097 Gene3D Ribonuclease Inhibitor 280 374 IPR032675 -
Vra5g0034 1097 SUPERFAMILY Protein kinase-like (PK-like) 792 1084 IPR011009 -
Vra5g0034 1097 SMART serkin_6 813 1084 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vra5g0034 1097 Pfam Leucine Rich repeat 149 164 IPR001611 GO:0005515
Vra5g0034 1097 Gene3D Ribonuclease Inhibitor 60 199 IPR032675 -
Vra5g0034 1097 MobiDBLite consensus disorder prediction 1 26 - -
Vra5g0034 1097 ProSitePatterns Protein kinases ATP-binding region signature. 819 842 IPR017441 GO:0005524
Vra5g0034 1097 Pfam Leucine Rich Repeat 641 663 IPR001611 GO:0005515
Vra5g0034 1097 Pfam Protein kinase domain 814 1082 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vra5g0034 1097 Gene3D Phosphorylase Kinase; domain 1 775 888 - -
Vra5g0034 1097 SUPERFAMILY L domain-like 239 698 - -
Vra5g0034 1097 ProSiteProfiles Leucine-rich repeat profile. 150 172 IPR001611 GO:0005515
Vra5g0034 1097 ProSiteProfiles Leucine-rich repeat profile. 641 663 IPR001611 GO:0005515
       

Duplication type information


Select Gene Chromosome Start End Duplicated_type
Vra5g0034 Vra-Chr5 290112 294299 Transposed
       

Functional genes information


Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vra5g0034 37 747 Miscellaneous Gene Families AT1G17240 51.524 0.0 647
       

Transcription factors information


Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-Xb-1 Vra5g0034 Pkinase 3.8e-39 CL0016
       

Pathway information


Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vra5g0034 - - gmx:100782574 1840.85